Abstract: In one example in accordance with the present disclosure, a computing device is described. The computing device includes an encryption device to encrypt, using an encryption key, a document to be rendered. A generating device generates multiple shares of a decryption key using a secret-sharing scheme. A threshold number of the multiple shares allows decryption of the document. A transmit device transmits different shares of the multiple shares to different devices. The document is rendered when the threshold number of multiple shares are rejoined at a rendering device.

Abstract: An apparatus is disclosed. The apparatus may comprise a storage medium to store: a first data structure to receive a first plurality of numerical identifiers, each numerical identifier of the first plurality of numerical identifiers corresponding to a respective signal received during a first defined time interval; and a second data structure to receive a second plurality of numerical identifiers, each numerical identifier of the second plurality of numerical identifiers corresponding to a respective signal received during a second defined time interval, wherein the first defined time interval is earlier in time than the second defined time interval. The apparatus may comprise a processor.

Abstract: Examples disclosed herein relate to determining whether to allow access to an IP address based on a security level and domain name access information. In one implementation, a processor intercepts a response to a Domain Name System request related to a domain name and updates a security level based on the request and/or response. The processor may determine whether to forward or block the response based on the security level and a comparison of the domain name to stored information related to previous domain name access.

Abstract: Described herein are methods of producing decellularized tissue hydrogels. In some aspects, the decellularized tissue hydrogels can contain one or more extracellular matrix proteins. Also described herein are methods of making the decellularized tissue hydrogels. Also described herein are methods of using the decellularized tissue hydrogels. In some aspects, the decellularized tissue hydrogels or a pre-gel solution can be administered to a subject.

Abstract: A compound having agonist activity at the GLP-1 (glucagon-like-peptide 1) and GLP-2 (glucagon-like peptide 2) receptors, and a pharmaceutical composition containing the compound or a pharmaceutically acceptable salt or solvate thereof in admixture with a pharmaceutically acceptable carrier, an excipient or a vehicle are provided. The compound can be used, inter alia, in the prophylaxis or treatment of intestinal damage and dysfunction, regulation of body weight, and prophylaxis or treatment of metabolic dysfunction.

Abstract: Examples associated with application approval are described. One example includes receiving an application package. The application package contains an application from a service provider and a privacy description for the application from a review provider. The application operates on private data controlled by a user. The application package is validated to ensure components of the application package is properly credentialed. An application summary for the user is generated from the privacy description. The application summary describes what portions of private data will be accessed by the application and how portions of the private data will be transmitted. An authorization is received from the user, and execution of the application is controlled based on the authorization of the user.

Abstract: Examples disclosed herein relate to selecting a security mitigation action based on device usage. In one implementation, a processor selects a security mitigation action for a device based on information related to usage of the device and associated usage limitations associated with the selected security mitigation action. The processor may output information related to the selected security mitigation action.

Abstract: A method for address resolution request control in a network device of a network, the method comprises comparing address resolution requests submitted to network nodes from the network device against a predetermined threshold profile for the network device, and regulating a flow of address resolution requests from the network device in response to the comparison.

Abstract: There is disclosed a method, computer program product and a system for regulating execution of a suspicious process, comprising determining a file system location of an executable file associated with the suspicious process, encrypting the file, and creating a wrapper for the file with the same file name and location as the file associated with the suspicious process.

Abstract: A compound having agonist activity at the GLP-1 (glucagon-like-peptide 1) and GLP-2 (glucagon-like peptide 2) receptors, and a pharmaceutical composition containing the compound or a pharmaceutically acceptable salt or solvate thereof in admixture with a pharmaceutically acceptable carrier, an excipient or a vehicle are provided. The compound can be used, inter alia, in the prophylaxis or treatment of intestinal damage and dysfunction, regulation of body weight, and prophylaxis or treatment of metabolic dysfunction.

Abstract: Examples associated with digital composition hashing are described. One example method includes receiving a digital composition file from a user. The digital composition file may include a top-level design and a hierarchy of sub-level designs. A hashed structure may be generated from the digital composition file, where a node in the hashed structure for the first sub-level design is generated based on hashes of sub-level designs below the first sub-level design in the hierarchy. The hashed structure and a hash of the digital composition file are stored in association with the user.

Abstract: An apparatus includes a first processing resource to execute a program code, and a second processing resource separate from the first processing resource. The program code includes an embedded execution unit. The execution unit, during execution of the program code, calculates a first security value for a part of the program code. The second processing resource runs a validation program. The validation program receives the first security value, checks the first security value against a second security value calculated from a corresponding part of a reference copy of the program code to obtain a check result, returns the check result to the execution unit. The execution unit performs a security-related action in response to a check result indicating a mismatch between the first security value and the second security value.

Abstract: A compound having agonist activity at the GLP-1 (glucagon-like-peptide 1) and GLP-2 (glucagon-like peptide 2) receptors, and a pharmaceutical composition containing the compound or a pharmaceutically acceptable salt or solvate thereof in admixture with a pharmaceutically acceptable carrier, an excipient or a vehicle are provided. The compound can be used, inter alia, in the prophylaxis or treatment of intestinal damage and dysfunction, regulation of body weight, and prophylaxis or treatment of metabolic dysfunction.

Abstract: Example implementations relate to facilitating scanning of protecting computing resources. In example implementations, a computing device receives a scan indicator that indicates an external agent is prepared to scan a protected resource of the computing device; identifies a protected action that may be performed by the data processor, the protected action facilitating scanning the protected resource of the computing device by the external agent, the protected action comprising a change in a state of the protected resource; performs the protected action; and provides the external agent with data indicating a current state of the protected resource.

Abstract: A compound having agonist activity at the GLP-1 (glucagon-like-peptide 1) and GLP-2 (glucagon-like peptide 2) receptors, and a pharmaceutical composition containing the compound or a pharmaceutically acceptable salt or solvate thereof in admixture with a pharmaceutically acceptable carrier, an excipient or a vehicle are provided. The compound can be used, inter alia, in the prophylaxis or treatment of intestinal damage and dysfunction, regulation of body weight, and prophylaxis or treatment of metabolic dysfunction.

Abstract: Examples associated with application approval are described. One example includes receiving an application package. The application package contains an application from a service provider and a privacy description for the application from a review provider. The application operates on private data controlled by a user. The application package is validated to ensure components of the application package is properly credentialed. An application summary for the user is generated from the privacy description. The application summary describes what portions of private data will be accessed by the application and how portions of the private data will be transmitted. An authorization is received from the user, and execution of the application is controlled based on the authorization of the user.

Abstract: An apparatus includes a first processing resource to execute a program code, and a second processing resource separate from the first processing resource. The program code includes an embedded execution unit. The execution unit, during execution of the program code, calculates a first security value for a part of the program code. The second processing resource runs a validation program. The validation program receives the first security value, checks the first security value against a second security value calculated from a corresponding part of a reference copy of the program code to obtain a check result, returns the check result to the execution unit. The execution unit performs a security-related action in response to a check result indicating a mismatch between the first security value and the second security value.

Abstract: Examples disclosed herein relate to selecting a security mitigation action based on device usage. In one implementation, a processor selects a security mitigation action for a device based on information related to usage of the device and associated usage limitations associated with the selected security mitigation action. The processor may output information related to the selected security mitigation action.

Abstract: Example implementations relate to facilitating scanning of protecting computing resources. In example implementations, a computing device receives a scan indicator that indicates an external agent is prepared to scan a protected resource of the computing device; identifies a protected action that may be performed by the date processor, the protected action facilitating scanning the protected resource of the computing device by the external agent, the protected action comprising a change in a state of the protected resource; performs the protected action; and provides the external agent with data indicating a current state of the protected resource.

Abstract: According to an example, statistics-based data trace classification may include generating sets of training data traces from training data information by assigning a subset of the training data information that has a predetermined property with a first label and assigning another subset of the training data information that does not have the predetermined property with a second label. A trained trace classifier may be generated to detect whether or not a set of input data traces satisfies the predetermined property. The trace classifier may be trained to learn the predetermined property from a statistical data object determined from the sets of the training data traces, and the first and second labels related to the sets of the training data traces.